PRDM1 and breast carcinoma: TGFβ1 and TGFβ2 are potent upstream regulators of Blimp1 in dermal fibroblasts (Figure 6a–c) and may potentially act via the c-RAF to AP-1 pathway identified in breast cancer cells (Romagnoli et al., 2012).